Association between Severity of Cannabis Dependence and Depression
- 1
- 2
Abstract
Objective. The aim of the current study was to investigate the relationship between self-reported severity of cannabis dependence and symptoms of depression. Method. The lifetime diagnoses of depression and cannabis misuse (abuse and/or dependence) were obtained from 50 participants recruited from the general community, using a self-completed diagnostic interview (CIDI-Auto 2.1). The lifetime severity of cannabis dependence was established using a standard questionnaire, Severity of Dependence Scale (SDS). Results. Of the 19 participants with mental illness diagnoses, 14 (74%) reported depression symptoms. The 14 participants with depression diagnoses had significantly more cannabis misuse diagnoses and significantly higher SDS scores compared to those without mental illness diagnoses (N = 31). SDS scores significantly predicted presence or absence of CIDI depression diagnoses with a 69% overall rate of cor-rect predictions. As SDS scores increased the odds of classification into depressed versus non-depressed groups was 1.3 (95% C.I. 1.02-1.57). Conclusion. The presence of lifetime depression symptoms is associated with higher lifetime severity of cannabis dependence and more lifetime cannabis misuse symptoms in otherwise healthy research vol-unteers.
- H. Verdoux, “Cannabis and psychosis proneness,” In D. Castle and R. Murray, Eds., Marijuana and Madness: Psychiatry and Neurobiology, Cambridge University Press, New York, 2004, pp. 75-88.
- L. Degenhardt, W. Hall, M. Lynskey, C. Coffey and G. Patton, “The Association between Cannabis Use and Depression: A Review of the Evidence,” In: D. Castle and R. Murray, Eds., Marijuana and Madness: Psychiatry and Neurobiology, Cambridge University Press, New York, 2004, pp. 54-74.
- American Psychiatric Association, “Diagnostic and Statistical Manual of Mental Disorders (DSM-IV),” American Psychiatric Association, 1994.
- K. Kedzior and M. Martin-Iverson, “Chronic Cannabis Use is Associated with Attention-Modulated Reduction in Prepulse Inhibition of the Startle Reflex in Healthy Humans,” Journal of Psychopharmacology, Vol. 20, No. 4, 2006, pp. 471-484.
- World Health Organi-zation, “Composite International Diagnostic Interview (CIDI), Version 2.1,” World Health Organisation, 1997.
- M. Gos-sop, S. Darke, P. Griffiths, J. Hando, B. Powis, W. Hall and J. Strang, “The Severity of Dependence Scale (SDS): Psychometric Properties of the SDS in English and Australian Samples of Heroin, Cocaine and Amphetamine Users,” Addiction, Vol. 90, 1995, pp. 607-614.
- K. Kedzior, J. Badcock and M. Mar-tin-Iverson, “Validity and Consistency of Self-Reports Regard-ing Substance Use in General Research Volunteers, Including Regular Cannabis Users and Schizophrenia Patients,” Substance Use and Misuse, Vol. 41, No. 5, 2006, pp. 743-750.
- C. Ferri, J. Marsden, M. de Araujo, R. Laranjeira and M. Gossop, “Validity and Reliability of the Severity of Dependence Scale (SDS) in a Brazilian Sample of Drug Users,” Drug & Alcohol Review, Vol. 19, No. 4, 2000, pp. 451-455.
- M. Gossop, D. Best, J. Marsden and J. Strang, “Test-Retest Reliability of the Severity of Dependence Scale (Comment),” Addiction, Vol. 92, No. 3, 1997, pp. 353.
- G. Martin, J. Copeland, P. Gates and S. Gilmour, “The Severity of Dependence Scale (SDS) in an Adolescent Population of Cannabis Users: Reliability, Validity and Diagnostic Cut-Off,” Drug and Alcohol Dependence, Vol. 83, No. 1, 2006, pp. 90-93.
- H.-U. Wittchen, “Reliability and Validity Studies of the WHO—Composite International Diagnostic Interview (CIDI): A Critical Review,” Journal of Psychiatric Research, Vol. 28, No. 1, 1994, pp. 57-84.
- G. Andrews and L. Peters, “The Psychometric Properties of the Composite International Diagnostic Interview,” Social Psychiatry & Psychiatric Epidemiology, Vol. 33, No. 2, 1998, pp. 80-88.